Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

Tesla stock rises in regular session as CPI looms and robotaxi deadlines return to focus

New York, January 12, 2026, 11:17 EST — Regular session

  • Tesla shares nudged up as investors grappled with inflation concerns and awaited the Fed’s next rate moves
  • The U.S. releases a crucial CPI report Tuesday; Tesla’s earnings follow later this month
  • Investors are closely eyeing if Tesla can finally meet its autonomy targets following multiple delays

Tesla shares climbed 0.7% to $448.09 in late morning trading Monday, after fluctuating between $438.01 and $449.91. The stock kicked off the day at $441.17, with roughly 23.7 million shares changing hands.

The timing is crucial as a major U.S. inflation report drops Tuesday, with the potential to shake up interest rate forecasts. The Consumer Price Index, tracking what Americans pay overall, is set for release at 8:30 a.m. ET. 1

Tesla is gearing up for its upcoming quarterly report, with investors eager to see new data on margins and demand following a volatile start to the year for growth stocks. The company’s investor relations calendar sets the fourth-quarter earnings release for Jan. 28. 2

Talk of Tesla’s 2026 roadmap has resurfaced this week, largely fueled by its autonomy ambitions. Morningstar analyst Seth Goldstein dubbed 2026 “the prove-it year for Tesla’s robotaxi business.” Elon Musk weighed in on the upcoming Cybercab, saying, “I think the demand will be pretty nutty.” Ashok Elluswamy, Tesla’s Autopilot and AI software lead, flagged more than six billion miles on supervised Full Self-Driving — Tesla’s driver-assistance system — as “a big milestone.” Still, AutoPacific’s Robby DeGraff cautioned that 2026 might prove “a bit of a challenge.” 3

Macro noise weighed on markets. Gold surged to a record $4,600 an ounce Monday after news of a criminal probe into Federal Reserve Chair Jerome Powell rattled investors, dragging Wall Street futures down earlier in the session. 4

Rates remain in focus. J.P. Morgan now expects the Fed to raise rates only in 2027, while Barclays and Goldman Sachs have shifted their forecast for rate cuts to mid-2026, Reuters reported. This follows data showing the labor market isn’t weakening quickly. Traders saw a 95% chance the Fed holds steady at its January meeting, per CME FedWatch via Reuters. 5

Tesla reported earlier this month that it produced more than 434,000 vehicles and delivered over 418,000 in the fourth quarter. The company also set a new high by deploying 14.2 gigawatt-hours of energy storage. 6

The stock remains priced like a promise, and those can easily unravel. A hiccup in expanding driverless service, stricter autonomous driving regulations, or renewed EV price cuts could hit hard—especially if bond yields climb once more.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus
Previous Story

Revolution Medicines stock slips as Truist sticks to $99 target with Merck buyout talk in focus

Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact
Next Story

Vistra stock jumps as VST taps debt markets; analysts recalibrate after Meta nuclear pact

Go toTop